首页> 外文期刊>Seminars in liver disease >Macrophages as a Cell-Based Therapy for Liver Disease
【24h】

Macrophages as a Cell-Based Therapy for Liver Disease

机译:巨噬细胞作为肝病的基于细胞疗法

获取原文
获取原文并翻译 | 示例
       

摘要

Liver failure arising from acute and chronic liver disease is an unmet clinical need that urgently requires novel therapeutic options in addition to orthotopic liver transplantation. Cell therapies offer new strategies to recover liver function through the reconstitution of healthy parenchyma and resolution of tissue pathology. Macrophages are professional phagocytes that comprise a key part of the innate immune system providing an important defense mechanism against invading pathogens. Macrophages are an inherently diverse cell type with respect to ontogeny, tissue distribution, phenotype, and function. The ability of macrophages to afford innate immunity, efficiently scavenge apoptotic/necrotic cells, and modulate local tissue microenvironment makes them an attractive cell therapy candidate for various diseases. This review aims to outline the rationale and utility of macrophages to serve as a potential cell therapy for liver disease.
机译:急性和慢性肝病引起的肝功能衰竭是一种未满足的临床需要,除了原位肝移植外,迫切需要新的治疗选择。 细胞疗法提供了通过重建健康实质和组织病理学来回收肝功能的新策略。 巨噬细胞是专业的吞噬细胞,其构成了先天免疫系统的关键部分,为入侵病原体提供了重要的防御机制。 巨噬细胞是一个具有固有不同的细胞类型,相对于组织,组织分布,表型和功能。 巨噬细胞能够提供先天免疫力,有效清除凋亡/坏死细胞的能力,并调节局部组织微环境使它们成为各种疾病的有吸引力的细胞疗法候选者。 该审查旨在概述巨噬细胞的理由和效用作为肝病的潜在细胞疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号